Innovating & Developing Medicine for Unmet Needs

About Us

Famy Life Sciences is a drug development platform focused on innovation in medicine and healthcare. We are engaged in identifying and developing best-in-class clinical-stage assets, to bring them to the market. We cover different therapeutics areas such as ophthalmology, oncology, dermatology and others.

Owned by the Taparia Group, who have a history of over 25 years in healthcare & pharmaceuticals. Their previous company, Famy Care Ltd, a women’s healthcare franchise, was acquired by Mylan Pharmaceuticals in 2015 for $800mm.

One of Our Key Focus Areas

Ophthalmology

At Famy Life Sciences, we identified ophthalmology as an area of immense opportunity with wide spaces. Over time, we have made significant investments to build a strong portfolio in ophthalmology, consisting of 6 late stage clinical assets in unmet and large disease areas such as dry eye, blepharitis and presbyopia amongst others.

Meet Our Core Team

  • Sanjeev Taparia

    CEO & Managing Director

  • Nidhi Taparia Agarwal

    Chief Business Officer

  • Anjali Taparia Biyani

    Chief Operations Officer

  • Shiladitya SenGupta

    Head - Scientific Affairs

“At Famy Life Sciences, we strive to make a difference to the Quality of Life of patients, by identifying best-in-class molecules in unmet areas, and endeavour to bring it to the market.”

— SANJEEV TAPARIA

Managing Director, Famy Life Sciences

“As a family, we stay committed to healthcare. We see a plethora of opportunities to innovate and create impact in the space.”

— NIDHI AGARWAL & ANJALI BIYANI

Directors, Famy Life Sciences

The Promoter Family

  • J P Taparia

  • Sanjeev Taparia

  • Ashutosh Taparia